TW260615B - - Google Patents

Info

Publication number
TW260615B
TW260615B TW82102545A TW82102545A TW260615B TW 260615 B TW260615 B TW 260615B TW 82102545 A TW82102545 A TW 82102545A TW 82102545 A TW82102545 A TW 82102545A TW 260615 B TW260615 B TW 260615B
Authority
TW
Taiwan
Application number
TW82102545A
Other languages
Chinese (zh)
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL10290592A external-priority patent/IL102905A/en
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of TW260615B publication Critical patent/TW260615B/zh

Links

TW82102545A 1992-08-21 1993-04-03 TW260615B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10290592A IL102905A (en) 1991-08-30 1992-08-21 An eye treatment product containing vitamin B21 for the neutralization of peroxide traces

Publications (1)

Publication Number Publication Date
TW260615B true TW260615B (fr) 1995-10-21

Family

ID=51626704

Family Applications (1)

Application Number Title Priority Date Filing Date
TW82102545A TW260615B (fr) 1992-08-21 1993-04-03

Country Status (1)

Country Link
TW (1) TW260615B (fr)

Similar Documents

Publication Publication Date Title
DK0553875T3 (fr)
TW262483B (fr)
BR9304651A (fr)
DK0574087T3 (fr)
DK0576346T3 (fr)
DK0571874T3 (fr)
DK0574276T3 (fr)
DK0581726T3 (fr)
DK0571172T3 (fr)
DK0559942T3 (fr)
TW235229B (fr)
TW222274B (fr)
DE9209779U1 (fr)
TW236679B (fr)
TW260615B (fr)
AU631518B2 (fr)
BRPI9204323A2 (fr)
IN186486B (fr)
IN177958B (fr)
IN180601B (fr)
CN3015538S (fr)
AU2527592A (fr)
CN3016198S (fr)
CN3016007S (fr)
AU634461B1 (fr)

Legal Events

Date Code Title Description
MC4A Revocation of granted patent